SOLTI-1502 ARIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer
Mafalda Oliveira1, Sonia Pernas2, Mireia Margelí3, Salvador Blanch4, Barbara Adamo5, Javier Salvador Bofill6, Diana Moreno7, Xavier Gonzalez-Farré8, José Rios9, Charles M Perou10, Aleix Prat11, Tomás Pascual11, Juan M Ferrero-Cafiero12, Patricia Villagrasa12 and Luis Manso13
Communication in congress
ePoster
SABCS
2020
